-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, STpjpUYaROTUTfWoR3QEvLc4aBG9jWDIyJyH1o14xSE6TSmh3hNsYXTEeLQS0ahZ ZziHNMppAUWAzSx2LuTjIQ== 0001140361-09-004346.txt : 20090217 0001140361-09-004346.hdr.sgml : 20090216 20090217165742 ACCESSION NUMBER: 0001140361-09-004346 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20090217 DATE AS OF CHANGE: 20090217 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Bollon Arthur CENTRAL INDEX KEY: 0001329091 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: BUSINESS PHONE: (972)620-2245 MAIL ADDRESS: STREET 1: 13227 CEDAR LANE CITY: DALLAS STATE: TX ZIP: 75234 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: HEMOBIOTECH, INC. CENTRAL INDEX KEY: 0001301348 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330995817 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-81482 FILM NUMBER: 09615105 BUSINESS ADDRESS: STREET 1: 5001 SPRING VALLEY ROAD STREET 2: SUITE 1040 - WEST CITY: DALLAS STATE: TX ZIP: 75244 BUSINESS PHONE: 972-455-8950 MAIL ADDRESS: STREET 1: 5001 SPRING VALLEY ROAD STREET 2: SUITE 1040 - WEST CITY: DALLAS STATE: TX ZIP: 75244 FORMER COMPANY: FORMER CONFORMED NAME: HEMOBIOTECH INC DATE OF NAME CHANGE: 20040824 SC 13G/A 1 doc1.htm Schedule 13G

United States
Securities and Exchange Commission
Washington, D.C. 20549

Schedule 13G

Under the Securities Exchange Act of 1934
(Amendment No. 03)*

OMB Number
3235-0145
HEMOBIOTECH INC.
(Name of Issuer)
Common Stock, $0.001 Par Value Per Share
(Title of Class of Securities)
42368P102
(CUSIP Number)
December 3 1, 2008
(Date of Event which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

  Rule 13d-1(b)
  Rule 13d-1(c)
√ Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 42368P102

  1. Names of Reporting Persons.
    I.R.S. Identification Nos. of above persons (entities only).

    Bollon Arthur
    00-00000000

  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    1.  
    2.  
  3. SEC Use Only
  4. Citizenship or Place of Organization

    United States of America

Number of Shares Beneficially Owned by Each Reporting Person With:

  1. Sole Voting Power

    1,445,726 Shares

  2. Shared Voting Power

    217,223 Shares

  3. Sole Dispositive Power

    1,445,726 Shares

  4. Shared Dispositive Power

    217,223 Shares

  1. Aggregate Amount Beneficially Owned by Each Reporting Person

    1,662,949 Shares (1)

  2. Check if the Aggregate Amount in Row 9 Excludes Certain Shares (See Instructions)    
  3. Percent of Class Represented by Amount in Row 9

    8.0%

  4. Type of Reporting Person (See Instructions)

    IN

Footnotes:

(1) Represents (a) 1,381,836 shares of common stock directly beneficially owned by Dr. Bollon; (b) 217,223 shares of common stock directly beneficially owned by Biogress LLC, of which Dr. Bollon is a founding member and has 50% voting power;and (c) options to purchase 63,890 shares of common stock directly beneficially owned by Dr. Bollon which vest within 60 days of the date hereof.

 

Item 1.

  1. Name of Issuer

    HemoBioTech, Inc.

  2. Address of Issuer's Principal Executive Offices

    5001 Spring Valley Rd, Suite 1040-West, Dallas, TX 75244

Item 2.

  1. Name of Person Filing

    Dr. Arthur Bollon

  2. Address of Principal Business Office or, if None, Residence

    c/o 5001 Spring Valley Rd, Suite 1040-West, Dallas, TX 75244

  3. Citizenship

    Bollon is a citizen of the United States of America

  4. Title of Class of Securities

    Common Stock, $0.001 Par Value Per Share

  5. CUSIP Number

    42368P102

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

  1.    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
  2.    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
  3.    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
  4.    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8).
  5.    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
  6.    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
  7.    A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);
  8.    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
  9.    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
  10.    Group, in accordance with §240.13d-1(b)(1)(ii)(J).

Item 4. Ownership

  1. Amount beneficially owned:

    1,662,949 Shares

  2. Percent of class:

    8.0%

  3. Number of shares as to which the person has:
    1. Sole power to vote or to direct the vote:

      1,445,726 Shares

    2. Shared power to vote or to direct the vote:

      217,223

    3. Sole power to dispose or to direct the disposition of:

      1,445,726 Shares

    4. Shared power to dispose or to direct the disposition of:

      217,223

Item 5. Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following    .

Not Applicable.

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not Applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company

Not Applicable.

Item 8. Identification and Classification of Members of the Group

None of the reporting persons who have filed this schedule is a person, as defined in Rule 13d-1(b)(1)(ii), promulgated pursuant to the Securities Exchange Act of 1934.

Item 9. Notice of Dissolution of Group

 

Item 10. Certification

Not applicable.

Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

February 17, 2009
Date
/s/ Arthur Bollon
Signature
Arthur Bollon
Name / Title

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties for whom copies are to be sent.

Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)

-----END PRIVACY-ENHANCED MESSAGE-----